Various cancers and tumorous conditions were treated by healers. A total of 47 plant species belonging to 42 genera and 30 families were documented and identified as anti-cancer and anti-diabetic herbal remedies in Northern Peru, with 31 plants used for diabetes treatment and 17 species used for conditions identified by local healers as cancer. Most species used were Asteraceae, followed by Gentianaceae. Asteraceae as the most important anti-cancer and anti-diabetic family was clearly overrepresented in comparison to the overall medicinal flora. The majority of anti-cancer and anti-diabetic herbal preparations were prepared from the leaves of the employed plants. Leaves and stems were more often used than characteristic for the overall medicinal preparations found in the region, while whole plants were employed less frequently. This indicates that the local healers count on a very well developed knowledge about the properties of different plant parts. In almost 60% of the cases fresh plant material was used to prepare remedies, which differs little from the average herbal preparation mode in Northern Peru. Over 90% of the remedies were applied orally. This is significantly different from the regional average of application. Over half of all remedies were prepared as mixtures with multiple ingredients by boiling plant material either in water or in sugarcane spirit. Little scientific evidence exists to date to prove the efficacy of the species employed as anti-cancer and anti-diabetic remedies in Northern Peru. Only 38.71% of the plants found to be used for diabetes treatments and 17.65% employed as anti-cancer remedies or related species in the same genus have been studied at all. Traditional medicines are still the main and often only choice for a large part of the global population. The information gained on frequently used traditional remedies against cancer and diabetes related illnesses might give some leads for future targets for further analysis in order to develop new drugs. However, more detailed scientific studies are desperately needed to evaluate the efficacy and safety of the remedies employed traditionally.
INTRODUCTION
According to World Health Organization (WHO) about 180 million people worldwide suffer from diabetes, with over 80% of them living in low and middle income countries. This number is expected to double by 2030. In Peru, an estimated 5.5% of the population is effected by this condition, and minimal Western healthcare is available for treatment. Likewise, cancer is the cause of *Corresponding author. E-mail: rainer.bussmann@mobot.org. Tel: +1-314-577-9503. Fax: +1-314-577-0800 about 13% of all deaths worldwide, with more than 70% of all cancers occurring in the developing world. Both diabetes and cancer impose a significant economic burden on individuals, families and the national economy. Traditional medicine is used globally and has rapidly growing economic importance (WHO 2009a, b; Wild et al., 2003) . In developing countries, traditional medicine is often the only accessible and affordable treatment available. In Latin America, the WHO Regional Office for the Americas (AMRO/PAHO) reports that 71% of the population in Chile and 40% of the population in Colombia has used traditional medicine. In many Asian countries traditional medicine is widely used, even though Western medicine is often readily available. In Japan, 60 to 70% of allopathic doctors prescribe traditional medicines for their patients. In the US the number of visits to providers of complementary alternative medicine (CAM) now exceeds by far the number of visits to all primary care physicians (WHO, 1999a (WHO, , b, 2002 .
Complementary alternative medicine is also becoming more and more popular in many developed countries. Forty-two percent of the population in the US have used complementary alternative medicine at least once (WHO, 1998) and a national survey reported the use of at least one of 16 alternative therapies increased from 34% in 1990 34% in to 42% in 1997 34% in (UNCCD, 2000 .
The expense for the use of traditional and complementary alternative medicine is exponentially growing in many parts of the world. The 1997 out-ofpocket complementary alternative medicine expenditure was estimated at US$ 2.7 billion in the USA. The world market for herbal medicines based on traditional knowledge is now estimated at US$ 60 billion (Breevort, 1998) . Northern Peru is believed to be the center of the Central Andean Health Axis (Camino, 1992) , and traditional medicinal practices in this region are still an important component of everyday life Bussmann, 2006; De Feo, 1992; Joralemon and Sharon, 1993; Polia, 1988; Sharon, 1978 Sharon, , 1980 Sharon, , 1994 Sharon, , 2000 Sharon and Bussmann, 2006) . Traditional medicine is also gaining more and more respect by national governments and health providers. Peru"s National Program in Complementary Medicine and the Pan American Health Organization recently compared complementary medicine to allopathic medicine in clinics and hospitals operating within the Peruvian Social Security System (Essalud, 2000) . According to WHO (2002) , the sustainable cultivation and harvesting of medicinal species is one of the most important challenges for the next few years.
MATERIALS AND METHODS

Plant collections
Plants in Peru were collected from field, markets and at the homes of traditional healers ( (Figure 1 ). The specimens were registered under the collection series "RBU/PL," "ISA," "GER," "JULS," "EHCHL," "VFCHL," "TRUBH," and "TRUVANERICA," depending on the year of fieldwork and collection location. Surveys were conducted in Spanish by fluent speakers. Surveyors would approach healers, collectors and market vendors and explain the premise for the study, including the goal of conservation of medicinal plants in the area. All were asked to participate but due to expected resistance, information could not be collected from everyone. From those who gave their prior informed consent, information was collected regarding their knowledge and inventory of medicinal plants. Vouchers of all specimens were deposited at the Herbario Bussmann and Glenn 6917 Truxillensis (HUT, Universidad Nacional de Trujillo), and Herbario Antenor Orrego (HAO, Universidad Privada Antenor Orrego Trujillo). In order to recognize Peru"s rights under the convention on biological diversity, most notably with regard to the conservation of genetic resources in the framework of a study treating medicinal plants, the identification of the plant material was conducted entirely in Peru. No plant material was exported in any form whatsoever.
Nomenclature
The nomenclature of plant families, genera and species follows the Catalogue of the Flowering Plants and Gymnosperms of Peru (Brako and Xarucchi, 1993) and the Catalogue of Vascular Plants of Ecuador (Jørgensen and León-Yanez, 1999) . The nomenclature was compared to the Tropicos database. Species were identified using the available volumes of the Flora of Peru (McBride, 1936 (McBride, -1981 , as well as Jørgensen and Ulloa (1994) , Pestalozzi (1998) and Ulloa and Jørgensen (1993) and the available volumes of the Flora of Ecuador (Sparre and Harling, 1978-2009 ) and reference material in the herbaria HUT, HAO, QCA, LOJA and QCNE.
RESULTS AND DISCUSSION
Fourty-seven plant species belonging to 42 genera and 30 families were used by curanderos in Northern Peru to treat cancerous conditions and diabetes symptoms. Most species used were Asteraceae (9 species, 19.15%), followed by Gentianaceae (3 species, 6.37%), and 7 families with 2 species each (4.25%). All other families contributed only one species each to the pharmacopoeia (Table 1) . A complete overview of all plants encountered, including data on use-recipes and preparation, is given in Appendix 1. Asteraceae as the most important anticancer and anti-diabetic family is clearly overrepresented in comparison to the overall medicinal flora, while most other medicinally important families are either under-represented or completely missing from the portfolio (Table 2 and Figure 2 ) . The majority of anti-cancer and anti-diabetic herbal preparations were prepared from the leaves of plants (30.77%), while the whole plant (20%), stems (20%) and flowers (6.15%) were used less frequently (Table 3) . Leaves and stems were more often used than characteristic for the overall medicinal preparations found in the region, while whole plants were employed less frequently (Figure 3 ), (Bussmann and Sharon, 2006a) . This indicates that the local healers count on a very well developed knowledge about the properties of different plant parts. In almost 60% of the cases fresh plant material was used to prepare remedies, which differs little from the average herbal preparation mode in Northern Peru (Table 4 and Figure 4 ). Over 90% of the remedies were applied orally, while the remaining ones were applied topically (Table 5) . This is significantly different from the regional average of application ( Figure 5 ). More than 50% of the remedies included multiple plants ( Figure 6 ). Little scientific evidence exists to date to prove the efficacy of the species employed as anti-cancer and (Lans, 2006; Bletter, 2007) and banana is also used in the Middle East (Azazieh et al., 2006) . Mulberries (Morus sp.) have been found as diabetes remedy both in the Mediterranean (Azazieh et al., 2006) and Trinidad (Lans, 2006) . Mimosa sp. is a traditional diabetes remedy in India (Sajem and Gosai, 2006) and the Caribbean (Lans, 2006) and the latter author also reported on Annona sp. and Aloe barbadensis used for this purpose. Aloe has indeed shown some efficacy for diabetes treatment (Wang et al., 2007; Hays et al., 2008) . Johnson (2006) India (Azazieh et al., 2006; Prakash Kala et al., 2006) . Olive has indeed shown to regulate glucose levels (Said et al., 2008) . Other studies refer to Artichokes (Cynara cardunculus) (Linde et al., 2001) , Chickpeas (Cicer arietinum) (Cummings, 1973) , Ocimum sp. (Aguiyi et al., 2000; Egsie et al., 2006) , Citrus spp. (Jaiyesimi, 2000) , 
Conclusions
Cancer and diabetes related illnesses are amongst the fastest rising health problems on the globe. Although western medicine has made large advances in therapy, no "silver bullet" has been found to date. Traditional medicines are still the main and often only choice for a large part of the global population. The information gained on frequently used traditional remedies against cancer and diabetes related illnesses might give some leads for future targets for further analysis in order to develop new drugs.
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